Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells.
Background: Certain antimitotic drugs have antitumor activities that apparently result from interactions with nontubulin components involved in cell growth and/or apoptotic cell death. Indanocine is a synthetic indanone that has been identified by the National Cancer Institute's Developmental Therap...
| Published in: | JNCI: Journal of the National Cancer Institute Vol. 92; no. 3; pp. 217 - 225 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | research Journal Article |
| Published: |
Oxford University Press / USA
02/02/2000
|
| Online Access: | View this record in EBSCOhost |